| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1470-2045(18)30763-0 |
| P698 | PubMed publication ID | 30658933 |
| P50 | author | Chris J L M Meijer | Q90379336 |
| Peter J F Snijders | Q90768556 | ||
| Willem Melchers | Q56859383 | ||
| Daniëlle A M Heideman | Q90379334 | ||
| P2093 | author name string | Leon F A G Massuger | |
| Johannes Berkhof | |||
| Ruud L M Bekkers | |||
| Folkert J van Kemenade | |||
| Wim G V Quint | |||
| Renée M F Ebisch | |||
| Anco C Molijn | |||
| Nicole J Polman | |||
| P2860 | cites work | Women's experience with home-based self-sampling for human papillomavirus testing | Q27311434 |
| Eurogin 2016 Roadmap: how HPV knowledge is changing screening practice | Q30239987 | ||
| STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration | Q30274888 | ||
| Non-inferiority and superiority tests for partially matched data when a constraint is placed on the number of new tests | Q30579744 | ||
| HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study | Q33721970 | ||
| Improved sensitivity of vaginal self-collection and high-risk human papillomavirus testing | Q33918589 | ||
| The effect of self-sampled HPV testing on participation to cervical cancer screening in Italy: a randomised controlled trial (ISRCTN96071600) | Q34543764 | ||
| High concordance of results of testing for human papillomavirus in cervicovaginal samples collected by two methods, with comparison of a novel self-sampling device to a conventional endocervical brush | Q34720012 | ||
| The Dutch CISOE-A framework for cytology reporting increases efficacy of screening upon standardisation since 1996. | Q35587534 | ||
| Pooled analysis of a self-sampling HPV DNA Test as a cervical cancer primary screening method | Q35742384 | ||
| A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings | Q36543787 | ||
| Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older | Q37461977 | ||
| Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis | Q38179114 | ||
| Reaching women who do not participate in the regular cervical cancer screening programme by offering self-sampling kits: a systematic review and meta-analysis of randomised trials. | Q38571169 | ||
| Prevalence of Human Papillomavirus in Self-Taken Samples from Screening Nonattenders. | Q40116201 | ||
| A randomized controlled trial in non-responders from Newcastle upon Tyne invited to return a self-sample for Human Papillomavirus testing versus repeat invitation for cervical screening | Q41658208 | ||
| Increasing participation in cervical cancer screening: offering a HPV self-test to long-term non-attendees as part of RACOMIP, a Swedish randomized controlled trial. | Q42262377 | ||
| A novel design for estimating relative accuracy of screening tests when complete disease verification is not feasible | Q45302196 | ||
| High-risk human papillomavirus detection in self-sampling compared to physician-taken smear in a responder population of the Dutch cervical screening: Results of the VERA study. | Q50853405 | ||
| Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico | Q58504458 | ||
| Three-tiered score for Ki-67 and p16 improves accuracy and reproducibility of grading CIN lesions | Q59356826 | ||
| Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial | Q61626075 | ||
| Reasons for non-attendance to cervical screening and preferences for HPV self-sampling in Dutch women | Q63914820 | ||
| High risk human papillomavirus in women with normal cervical cytology prior to the development of abnormal cytology and colposcopy | Q73824709 | ||
| P433 | issue | 2 | |
| P921 | main subject | cervical intraepithelial neoplasia | Q196788 |
| P304 | page(s) | 229-238 | |
| P577 | publication date | 2019-01-15 | |
| P1433 | published in | Lancet Oncology Commission | Q13747613 |
| P1476 | title | Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial | |
| P478 | volume | 20 |
| Q64080785 | Cross-sectional study of HPV testing in self-sampled urine and comparison with matched vaginal and cervical samples in women attending colposcopy for the management of abnormal cervical screening |
| Q91759512 | Experience with HPV self-sampling and clinician-based sampling in women attending routine cervical screening in the Netherlands |
| Q99564269 | Extended HPV genotyping to compare HPV type-distribution in self and provider-collected samples for cervical cancer screening |
| Q92593211 | HPV self-testing for primary cervical cancer screening in Madagascar: VIA/VILI triage compliance in HPV-positive women |
| Q89695844 | High-risk human papillomavirus prevalence in self-collected cervicovaginal specimens from human immunodeficiency virus (HIV)-negative women and women living with HIV living in Botswana |
| Q91841838 | Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study |
| Q91910518 | Introduction of primary screening using high-risk HPV DNA detection in the Dutch cervical cancer screening programme: a population-based cohort study |
| Q92639475 | Long-term CIN3+ risk of HPV positive women after triage with FAM19A4/miR124-2 methylation analysis |
| Q91116249 | Self-collected versus clinician-collected samples for HPV testing |
Search more.